HFWM: evaluating the importance of myeloperoxidase in the early anticipation of subsequent chronic heart failure occurrences in individuals after st-segment elevation acute myocardial infarction

Back

HFA Premium Access

HFWM: evaluating the importance of myeloperoxidase in the early anticipation of subsequent chronic heart failure occurrences in individuals after st-segment elevation acute myocardial infarction

Session: ePosters in basic science 2

Topic: Biomarkers

Speaker: Associate Professor I. Vyshnevska (Kharkiv, UA)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Associate Professor Iryna Vyshnevska

L.T. Malaya Therapy National institute of NAMSU, Kharkiv (Ukraine)

1 presentation

0 follower

7 more presentations in this session

DETECT-Heart: biomarkers for screening of patients referred to the cardiovascular outpatient clinic

Speaker: Mr C. Geraeds (Maastricht, NL)

The predictive value of matrix metalloproteinase-9 as an inflammation marker in anticipating adverse events one year after experiencing a st-elevation myocardial infarction

Speaker: Associate Professor I. Vyshnevska (Kharkiv, UA)

The novel myosin activator, danicamtiv alters both systolic and diastolic functions in vitro and in vivo

Speaker: Doctor A. Raduly (Debrecen, HU)

MicroRNA-based network analysis identified the NOVA1 gene as a potential new target in end-stage heart failure

Speaker: Miss T. Balint (Budapest, HU)

Novel insights in cardiac fibrosis in HFpEF: potential role of UBALD2-enriched endothelial extracellular vesicles

Speaker: Miss B. Losada Fuentenebro (Pamplona, ES)

Access the full session

ePosters in basic science 2

Speakers: Associate Professor I. Vyshnevska, Mr C. Geraeds, Associate Professor I. Vyshnevska, Doctor A. Raduly, Miss T. Balint...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources